CLOV Stock Summary and Trading Ideas (Clover Health Investments Corp. - Class A | NASDAQ:CLOV)

Clover Health Investments Corp is a healthcare technology company. It focuses on empowering Medicare physicians to proactively manage chronic diseases through its proprietary software platform, Clover Assistant. This cloud-based solution provides personalized insights to physicians, enabling early detection and management of chronic conditions. It operates in one segment: Insurance, through which it offers PPO and HMO plans to Medicare Advantage members in several states.

Clover Health Investments Corp. - Class A trades on the NASDAQ stock market under the symbol CLOV.

As of April 2, 2026, CLOV stock price climbed to $1.72 with 3,153,582 million shares trading.

CLOV has a beta of 1.04, meaning it tends to be more sensitive to market movements. CLOV has a correlation of 0.06 to the broad based SPY ETF.

CLOV has a market cap of $888.69 million. This is considered a Small Cap stock.

Last quarter Clover Health Investments Corp. - Class A reported $488 million in Revenue and -$.10 earnings per share. This beat revenue expectation by $18 million and missed earnings estimates by -$.03.

In the last 3 years, CLOV traded as high as $4.87 and as low as $.61.

The top ETF exchange traded funds that CLOV belongs to (by Net Assets): VTI, IWM, VXF, IWO, VTWO.

CLOV has underperformed the market in the last year with a price return of -52.1% while the SPY ETF gained +18.2%. CLOV has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -26.8% and -8.5%, respectively, while the SPY returned -3.6% and -0.6%, respectively.

CLOV support price is $1.65 and resistance is $1.75 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that CLOV shares will trade within this expected range on the day.